Found 922 articles for: "acne"
ARTICLE: Colloidal Oatmeal Part I: History, Basic Science, Mechanism of Action, and Clinical Efficacy in the Treatment of Atopic Dermatitis
October 2020 | Volume 19 | Issue 10 | Supplement Individual Articles | s4 | Copyright © October 2020
Colloidal oatmeal has a long-standing history in the treatment of dermatologic disease. It is composed of various phytochemicals, which contribute to its wide-ranging function and clinical use. It has...
Read MoreCutaneous Manifestations of EGFR-Inhibitors in African Americans and Treatment Considerations
September 2020 | Volume 19 | Issue 9 | Case Reports | 894 | Copyright © September 2020
Epidermal growth factor (EGFR)-inhibitors have emerged as the primary therapy in advanced solid tumor malignancies because of improvement in survival with overall favorable side effect profile. Howeve...
Read MoreSystemic Medications of Dermatological Importance in COVID-19
September 2020 | Volume 19 | Issue 9 | Original Article | 889 | Copyright © September 2020
Early December 2019 witnessed an international outbreak of a novel coronavirus (COVID 19) designated severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2). Since then, a number of therapeutic m...
Read MoreThe Impact of COVID-19 on the Faces of Frontline Healthcare Workers
September 2020 | Volume 19 | Issue 9 | Original Article | 858 | Copyright © September 2020
As the coronavirus epidemic continues, a host of new cutaneous complications is seen on the faces of frontline healthcare workers wearing personal protective equipment on a daily basis. To minimize th...
Read MoreTopical Cannabinoids for the Management of Psoriasis Vulgaris: Report of a Case and Review of the Literature
August 2020 | Volume 19 | Issue 8 | Case Reports | 795 | Copyright © August 2020
Increased Trend of Cosmetic Procedures in Patients With Psoriasis Who Attain 75% or Greater Improvement
August 2020 | Volume 19 | Issue 8 | Original Article | 698 | Copyright © August 2020
Background: The relationship between the clearance of psoriasis and improved quality of life together with an increased uptake of cosmetic procedures has not been reported to date.
Read More Post-Inflammatory Hyperpigmentation: A Review of Treatment Strategies
August 2020 | Volume 19 | Issue 8 | Original Article | 763 | Copyright © August 2020
Post-inflammatory hyperpigmentation (PIH) is a reactive process resulting from increased melanin or abnormal distribution of melanin secondary to inflammatory skin conditions, dermatologic therapies, ...
Read MoreOral Metformin for Treating Dermatological Diseases: A Systematic Review
August 2020 | Volume 19 | Issue 8 | Original Article | 713 | Copyright © August 2020
Introduction:Metformin is an antihyperglycemic medication most commonly used to treat Type II Diabetes Mellitus with promising off-label application for the treatment of hidradenit...
Read MoreOnce-Daily Polymeric Tazarotene 0.045% Lotion for Moderate-to-Severe Acne: Pooled Phase 3 Analysis by Sex
August 2020 | Volume 19 | Issue 8 | Original Article | 777 | Copyright © August 2020
Background: Two identical phase 3 randomized, double-blind, vehicle-controlled, 12-week studies (NCT03168321 and NCT03168334) demonstrated the efficacy and safety of tazarotene 0.045%...
Read MoreRoflumilast Cream Improves Signs and Symptoms of Plaque Psoriasis: Results from a Phase 1/2a Randomized, Controlled Study
August 2020 | Volume 19 | Issue 8 | Original Article | 734 | Copyright © August 2020
Background: Roflumilast cream (ARQ-151) is a highly potent, selective phosphodiesterase-4 inhibitor in development for once-daily topical treatment of chronic plaque psoriasis.
...
Read MoreSafety and Efficacy of Clobetasol Propionate 0.05% Emollient Foam for the Treatment of Central Centrifugal Cicatricial Alopecia
July 2020 | Volume 19 | Issue 7 | Original Article | 719 | Copyright © July 2020
Background: There is currently an unmet need for the treatment of women with central centrifugal cicatricial alopecia (CCCA).
Objective: To evaluate the safety ...
Read MoreNovel Polymeric Tazarotene 0.045% Lotion for Moderate-to-Severe Acne: Pooled Phase 3 Analysis by Race/Ethnicity
July 2020 | Volume 19 | Issue 7 | Original Article | 727 | Copyright © July 2020
Background: Acne vulgaris and inflammation-associated sequelae are highly prevalent in black and Hispanic populations. In a phase 2 study, a novel polymeric emulsion formulation of ta...
Read MoreThe Use of Botanical Extracts in East Asia for Treatment of Hyperpigmentation: An Evidenced-Based Review
July 2020 | Volume 19 | Issue 7 | Original Article | 758 | Copyright © July 2020
Recent years have seen a growth in the Asian cosmeceutical industry and an expanding worldwide marketplace with increasing consumer use of plant-based skin care products. The rising prevalence of Asia...
Read MoreAn Analysis of Skin of Color Dermatology Related Content on Instagram
July 2020 | Volume 19 | Issue 7 | Original Article | 746 | Copyright © July 2020
Importance: Social media is making information about skin of color more readily available to those unfamiliar with ethnic skin and hair. Objectives: To answer: 1) wha...
Read MoreConsensus on Neonatal Through Preadolescent Acne
June 2020 | Volume 19 | Issue 6 | Original Article | 592 | Copyright © June 2020
Background: Acne vulgaris is the most common dermatological disorder. Pediatric acne may be a manifestation of the underlying pathology and can occur in the first weeks, months, or ye...
Read MoreUnited States Stock Market Response to FDA Approval of New Dermatologic Drugs
June 2020 | Volume 19 | Issue 6 | Original Article | 639 | Copyright © June 2020
Background: The Food and Drug Administration (FDA) has approved several new dermatologic drugs in the last decade. The public response to their approval has not yet been evaluated.
Read More Treatment of Moderate to Severe Acne and Scars With a 650-Microsecond 1064-nm Laser and Isotretinoin
June 2020 | Volume 19 | Issue 6 | Original Article | 646 | Copyright © June 2020
Background: Laser procedures for acne and acne scars have traditionally been postponed for at least 6 to 8 months after the end of systemic isotretinoin therapy. Lower dosages with mo...
Read MoreOutpatient Teledermatology Implementation During the COVID-19 Pandemic: Challenges and Lessons Learned
June 2020 | Volume 19 | Issue 6 | Features | 683 | Copyright © June 2020
The Effect of Isotretinoin on Vitiligo and Autoimmune Comorbidity
June 2020 | Volume 19 | Issue 6 | Original Article | 637 | Copyright © June 2020
Several case reports have noted development of vitiligo as a potential side-effect of isotretinoin. In an IRB approved on-line survey of vitiligo patients we queried 1,301 vitiligo patients, 1115 with...
Read MoreVirtual Exams No Substitute for In-Person Care of Acne and Rosacea
June 2020 | Volume 19 | Issue 6 | Editorials | 582 | Copyright © June 2020